cytarabine and Cerebellar Diseases

cytarabine has been researched along with Cerebellar Diseases in 33 studies

Research

Studies (33)

TimeframeStudies, this research(%)All Research%
pre-199019 (57.58)18.7374
1990's8 (24.24)18.2507
2000's5 (15.15)29.6817
2010's1 (3.03)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corral Corral, Í; de Felipe Mimbrera, A; Jiménez Martín, A; Sainz de la Maza Cantero, S1
Ifrah, N; Leboucher, B; Pellier, I; Rachieru, P; Rialland, X1
Bleyer, A1
Agarwal, RP; Lopez, JA1
Lazarus, HM1
Abe, Y; Nakao, K; Ohota, S; Ohoya, N; Shimada, M; Yamano, T1
Beaudreuil, J; Casassus, P; Guillevin, L; Jarrousse, B; Lortholary, O; Salama, J1
Chim, CS; Kwong, YL1
Forman, SJ; Hinton, DR; Openshaw, H; Slatkin, NE; Stein, AS1
Olavarria, E; Prieto, E; Roman, A1
Aird, W; Amrein, P; MacNeill, K; Neuberg, D; Shulman, LN; Sternberg, DW; Thompson, L1
Arber, D; Dagis, A; Forman, SJ; Margolin, KA; Nademanee, A; Niland, J; O'Donnell, MR; Parker, PM; Schmidt, GM; Slovak, ML; Smith, EP; Snyder, DS; Somlo, G; Stein, AS1
Friedman, JH; Grace, J; Shetty, N; Zawacki, T1
Bosco, L; Bufton, MG; Faich, GA; Flynn, B; Gerstman, BB; Jolson, HM; Rinsler, SS; Simmons, WD; Stadel, BV; Williams, E1
Crocker, I; Dobbs, CK; Gordon, DS; Heffner, LT; Reynolds, R; Sternberg, P; Vogler, WR; Winton, EF1
Hasle, H1
Mahaney, FX1
Bologna, S; Link, MP; Miller, L; Parker, BR1
Boesen, P; Fallingborg, J; Spaun, E1
Carter, RT; Cersosimo, RJ; Coderre, M; Karp, DD; Matthews, SJ1
Durmaz, R; Ucar, K1
Cold, S1
Castellanos, AM; Glass, JP; Keating, MJ; Ventura, GJ1
Talstad, I; Thordarson, H1
Fisher, AJ; Lobell, M; Sylvester, RK1
Adelstein, DJ; Brown, RA; Cassileth, PA; Coccia, PF; Herzig, GP; Herzig, RH; Hines, JD; Lazarus, HM; Strandjord, S; Wolff, SN1
Fay, JW; Herzig, GP; Herzig, RH; Hines, JD; Phillips, GL; Wolff, SN1
Capizzi, RL; Powell, BL1
Durie, BG; Garewal, H; Greenberg, B1
Barnett, MJ; Butler, MG; Ganesan, TS; Lister, TA; Richards, MA; Rohatiner, AZ; Slevin, ML; Smith, BF; Waxman, JH1
Benger, A; Browman, GP; Preisler, HD; Walker, IR1
Dworkin, LA; Fuchs, PC; Goldman, RD; Zivin, LS1
Estey, EH; Fields, WS; Hwang, TL; Yung, WK1

Reviews

1 review(s) available for cytarabine and Cerebellar Diseases

ArticleYear
Cerebellar toxicity during cytarabine therapy associated with renal insufficiency.
    Cancer chemotherapy and pharmacology, 1990, Volume: 27, Issue:1

    Topics: Acute Kidney Injury; Aged; Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Humans; Lung Neoplasms; Male; Risk Factors

1990

Trials

1 trial(s) available for cytarabine and Cerebellar Diseases

ArticleYear
Central nervous system toxicity of high-dose cytosine arabinoside.
    Seminars in oncology, 1985, Volume: 12, Issue:2 Suppl 3

    Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Cerebellar Diseases; Clinical Trials as Topic; Cytarabine; Dose-Response Relationship, Drug; Drug Evaluation; Epilepsy, Tonic-Clonic; Female; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Lymphoma; Male; Middle Aged; Nystagmus, Pathologic; Syndrome; Tremor

1985

Other Studies

31 other study(ies) available for cytarabine and Cerebellar Diseases

ArticleYear
Cerebellar toxicity due to cytarabine: A series of 4 cases.
    Neurologia (Barcelona, Spain), 2016, Volume: 31, Issue:7

    Topics: Aged; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Humans; Liver Failure, Acute; Magnetic Resonance Imaging; Middle Aged

2016
Flushing out of cerebrospinal fluid as a therapy for acute cerebellar dysfunction caused by high dose of cytosine arabinoside: a case report.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:12

    Topics: Adolescent; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cerebrospinal Fluid; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male

2006
"Flushing out" cytosine arabinoside from CSF to reverse neurotoxicity.
    Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:4

    Topics: Adolescent; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cerebrospinal Fluid; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male

2007
Acute cerebellar toxicity after high-dose cytarabine associated with CNS accumulation of its metabolite, uracil arabinoside.
    Cancer treatment reports, 1984, Volume: 68, Issue:10

    Topics: Arabinofuranosyluracil; Carcinoma, Small Cell; Cerebellar Diseases; Cytarabine; Humans; Lung Neoplasms; Male; Middle Aged; Uridine

1984
Acute cerebellar dysfunction with high-dose Ara-C therapy.
    Cancer, 1984, Jun-15, Volume: 53, Issue:12

    Topics: Acute Disease; Adult; Cerebellar Diseases; Cytarabine; Humans; Leukemia

1984
Formation of heterotopic granule cell in mouse cerebellum after neonatal administration of cytosine arabinoside.
    Acta neuropathologica, 1980, Volume: 49, Issue:1

    Topics: Age Factors; Animals; Axons; Cell Movement; Cerebellar Cortex; Cerebellar Diseases; Cerebellum; Cytarabine; Mice; Microscopy, Electron; Purkinje Cells; Synapses

1980
[Cerebellar toxicity of cytosine-arabinoside in a young man following cerebral anoxia].
    Annales de medecine interne, 1995, Volume: 146, Issue:8

    Topics: Adult; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cytarabine; Humans; Hypoxia, Brain; Male

1995
Cerebellar toxicity with medium-dose cytarabine in a young patient with renal insufficiency.
    American journal of hematology, 1996, Volume: 53, Issue:3

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Daunorubicin; Female; Humans; Kidney; Kidney Failure, Chronic; Leukemia, Myeloid; Lupus Nephritis; Mitoxantrone

1996
Acute polyneuropathy after high dose cytosine arabinoside in patients with leukemia.
    Cancer, 1996, Nov-01, Volume: 78, Issue:9

    Topics: Acute Disease; Adult; Antimetabolites, Antineoplastic; Cerebellar Diseases; Cytarabine; Demyelinating Diseases; Female; Humans; Leukemia; Male; Middle Aged; Peripheral Nervous System Diseases; Retrospective Studies

1996
Retreatment with low-dose cytarabine in patients with previous central nervous system toxicity.
    American journal of hematology, 1997, Volume: 54, Issue:4

    Topics: Cerebellar Diseases; Cytarabine; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged

1997
Treatment of patients with recurrent and primary refractory acute myelogenous leukemia using mitoxantrone and intermediate-dose cytarabine: a pharmacologically based regimen.
    Cancer, 2000, May-01, Volume: 88, Issue:9

    Topics: Adult; Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cerebellar Diseases; Cytarabine; Death, Sudden, Cardiac; Disease-Free Survival; Drug Eruptions; Exanthema; Female; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Neoplasm Recurrence, Local; Neutropenia; Remission Induction; Thrombocytopenia; Treatment Outcome

2000
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission.
    Leukemia, 2000, Volume: 14, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Logistic Models; Male; Middle Aged; Prognosis; Remission Induction; Retrospective Studies; Sepsis; Translocation, Genetic; Treatment Outcome

2000
Cerebellar toxicity of cytosine arabinoside: clinical and neuropsychological signs.
    Neurology, 2000, Oct-24, Volume: 55, Issue:8

    Topics: Adult; Cerebellar Diseases; Cerebellum; Cytarabine; Humans; Magnetic Resonance Imaging; Male

2000
Clustering of adverse drug events: analysis of risk factors for cerebellar toxicity with high-dose cytarabine.
    Journal of the National Cancer Institute, 1992, Apr-01, Volume: 84, Issue:7

    Topics: Adolescent; Adult; Aged; Cerebellar Diseases; Cerebellum; Cohort Studies; Creatinine; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Risk Factors

1992
Ophthalmological and other toxicities related to cytosine arabinoside and total body irradiation as preparative regimen for bone marrow transplantation.
    Bone marrow transplantation, 1990, Volume: 6, Issue:6

    Topics: Bone Marrow Transplantation; Cerebellar Diseases; Cyclosporins; Cytarabine; Diarrhea; Evaluation Studies as Topic; Female; Georgia; Humans; Leukemia; Lymphoma; Male; Methotrexate; Myelodysplastic Syndromes; Preoperative Care; Remission Induction; Retinitis; Survival Rate; Transplantation, Autologous; Transplantation, Homologous; Whole-Body Irradiation

1990
Physicians warned of high-dose cytarabine.
    Journal of the National Cancer Institute, 1990, Feb-21, Volume: 82, Issue:4

    Topics: Cerebellar Diseases; Cytarabine; Drug Industry; Humans; Therapeutic Equivalency; United States; United States Food and Drug Administration

1990
Cerebellar atrophy caused by high-dose cytosine arabinoside: CT and MR findings.
    AJR. American journal of roentgenology, 1989, Volume: 152, Issue:2

    Topics: Atrophy; Cerebellar Diseases; Cerebellum; Child, Preschool; Cytarabine; Humans; Leukemia, Promyelocytic, Acute; Magnetic Resonance Imaging; Male; Tomography, X-Ray Computed

1989
Severe persistent cerebellar dysfunction complicating cytosine arabinoside therapy.
    Acta medica Scandinavica, 1988, Volume: 224, Issue:2

    Topics: Adult; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Purkinje Cells

1988
Acute cerebellar syndrome, conjunctivitis, and hearing loss associated with low-dose cytarabine administration.
    Drug intelligence & clinical pharmacy, 1987, Volume: 21, Issue:10

    Topics: Aged; Cerebellar Diseases; Conjunctivitis; Cytarabine; Hearing Disorders; Humans; Male; Primary Myelofibrosis

1987
High-dose chemotherapy regimens.
    Medical hypotheses, 1986, Volume: 19, Issue:2

    Topics: Cerebellar Diseases; Cytarabine; Half-Life; Humans; Leukemia, Myeloid, Acute; Oxygen Inhalation Therapy

1986
Cerebellar dysfunction during high dose cytosine arabinoside therapy in a case of acute myelogenous leukaemia.
    Scandinavian journal of haematology, 1986, Volume: 36, Issue:2

    Topics: Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Female; Humans; Leukemia, Myeloid, Acute; Middle Aged

1986
Reversible bilateral lateral rectus muscle palsy associated with high-dose cytosine arabinoside and mitoxantrone therapy.
    Cancer, 1986, Oct-15, Volume: 58, Issue:8

    Topics: Adult; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Ophthalmoplegia

1986
Acute meningitis and cerebellar dysfunction complicating high-dose cytosine arabinoside therapy.
    Acta medica Scandinavica, 1986, Volume: 220, Issue:5

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia, Lymphoid; Meningitis; Meningitis, Aseptic

1986
Cytarabine-induced cerebellar syndrome: case report and literature review.
    Drug intelligence & clinical pharmacy, 1987, Volume: 21, Issue:2

    Topics: Cerebellar Diseases; Cytarabine; Humans; Leukemia, Myeloid; Male; Middle Aged

1987
Cerebellar toxicity with high-dose cytosine arabinoside.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Cerebellar Diseases; Child; Child, Preschool; Cytarabine; Female; Humans; Infant; Leukemia; Lymphoma; Male; Middle Aged

1987
Central nervous system effects of high-dose cytosine arabinoside.
    Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1

    Topics: Adult; Age Factors; Aged; Cerebellar Diseases; Cytarabine; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Leukemia; Middle Aged

1987
Sequential high-dose ara-C and asparaginase versus high-dose ara-C alone in the treatment of patients with relapsed and refractory acute leukemias.
    Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1

    Topics: Acute Disease; Asparaginase; Cerebellar Diseases; Cytarabine; Diarrhea; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Leukemia; Neoplasm Recurrence, Local

1987
High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
    Oncology, 1987, Volume: 44, Issue:6

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Daunorubicin; Gastrointestinal Diseases; Humans; Leukemia; Recurrence; Remission Induction; Thioguanine

1987
Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report.
    Cancer treatment reports, 1985, Volume: 69, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged

1985
Cerebellar toxicity following high-dose cytosine arabinoside.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:5

    Topics: Ataxia; Cerebellar Diseases; Cytarabine; Dysarthria; Humans; Leukemia; Male; Middle Aged; Purkinje Cells

1985
Central nervous system toxicity with high-dose Ara-C.
    Neurology, 1985, Volume: 35, Issue:10

    Topics: Adolescent; Adult; Aged; Brain Diseases; Central Nervous System Diseases; Cerebellar Diseases; Cytarabine; Female; Humans; Leukemia; Male; Middle Aged

1985